… of the use of angiotensin converting enzyme inhibitors (ACE-I) … ACE-I in patients with
cardiovascular disease. The Task Force members for the Angiotensin Converting Enzyme Inhibitors …

… We also see the present guidance as a companion document to the European Society of
Cardiology guidelines on the diagnosis and treatment of HF which have also recently been …

… ACE inhibitors, specifically perindopril, beyond that provided by BP reduction, and potentially
reflects a mechanistic feature of the ACE inhibitors… the efficacy of ACE inhibitors as first-line …

… Current evidence based guidelines of the European Society … angiotensin-converting-enzyme
inhibitors (ACE-inhibitors), or angiotensin II receptor blockers (ARBs) when ACE-inhibitors …

… The study’s patients must have essential hypertension or pre-hypertension according to
diagnostic criteria established by the European Society of Hypertension 2013 guidelines. …

One of the most important challenges for scientific societies responsible for the development
of guidelines, is to provide regular update of recommendations when new data become …

… Only patients who were NOT taking an ACE-inhibitor in the Val-HeFT study are included
in this analysis. Exact pooled odds ratios shown. Test for heterogeneity P=0.2. …

… cardiac patients in whom ACE-inhibitors (ACE-Is) cannot … angiotensin converting enzyme
inhibitors in cardiovascular disease. The task force on ACE-inhibitors of the European Society …

… .1,2 The European Society of Cardiology guidelines for the … societies.3 These guidelines
emphasize in particular the beneficial effects of angiotensin-converting enzyme-inhibitors (ACE-I…

… Five molecules were recommended by the European Society of Cardiology in 2016 [2]: …
effects of ACE inhibitors, based on a meta-analysis that compared ACE inhibitors versus placebo …